During the past decade, Hospital Marina Baixa conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Marina Baixa" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Hospital Universitario de Valme" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Francisco Colomina Climent" with 1 trials sponsored and "Fundacion SEIMC-GESIDA" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Marina Baixa" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Spanish Network for Research in Infectious Diseases" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Marina Baixa" are "Psoriasis" (2 trials), "Rheumatoid Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Allergic Rhinoconjunctivitis" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Hospital Marina Baixa" in a lesser frequency.

Most popular intervention types in "Hospital Marina Baixa" are "Drug" (13 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (4 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Marina Baixa" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Marina Baixa". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Marina Baixa, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Marina Baixa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".